JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Ampofo, W.
Right arrow Articles by Ishikawa, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Ampofo, W.
Right arrow Articles by Ishikawa, K.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, September 2002, p. 3523-3525, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3523-3525.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.

Prevalence of Blood-Borne Infectious Diseases in Blood Donors in Ghana

William Ampofo,1* Nicholas Nii-Trebi,1 Justina Ansah,2 Kenji Abe,3 Hideo Naito,3 Simeon Aidoo,1 Victor Nuvor,1 James Brandful,1 Naoki Yamamoto,4 David Ofori-Adjei,1 and Koichi Ishikawa3

Noguchi Memorial Institute for Medical Research, University of Ghana, Legon,1 National Blood Transfusion Service, Ministry of Health, Korle Bu, Accra, Ghana,2 AIDS Research Centre, National Institute for Infectious Diseases,3 Microbiology Department, Tokyo Medical and Dental University, Tokyo, Japan4

Received 11 June 2001/ Returned for modification 14 August 2001/ Accepted 13 June 2002

Transfusion-transmissible infections among 808 blood donors in Ghana were investigated in 1999. Antibody seroprevalences of 3.8, 0.7, 8.4, and 13.5%, respectively, for human immunodeficiency virus, human T-cell lymphotrophic virus type 1, hepatitis C virus (HCV), and Treponema pallidum were obtained. The seroprevalence of HCV infection was confirmed to be 0.9% after supplementary testing, and the transfusion risk potential of these pathogens was demonstrated.


* Corresponding author. Mailing address: Noguchi Memorial Institute for Medical Research, University of Ghana, P.O. Box LG581 Legon, Accra, Ghana. Phone: 233-21-501178/9. Fax: 233-21-502182. E-mail: wampofo{at}noguchi.mimcom.net or wampofo{at}hotmail.com.


Journal of Clinical Microbiology, September 2002, p. 3523-3525, Vol. 40, No. 9
0095-1137/02/$04.00+0     DOI: 10.1128/JCM.40.9.3523-3525.2002
Copyright © 2002, American Society for Microbiology. All Rights Reserved.




This article has been cited by other articles:




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2002 by the American Society for Microbiology. All rights reserved.